• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剖腹术会促进腹腔内肿瘤生长,并消除白细胞介素-2和淋巴因子激活的杀伤细胞的抗肿瘤作用。

Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells.

作者信息

Eggermont A M, Steller E P, Sugarbaker P H

出版信息

Surgery. 1987 Jul;102(1):71-8.

PMID:3495896
Abstract

The interrelationship between host resistance to cancer and the trauma of a surgical procedure is the subject of much speculation. Extensive study of animal models and human subjects is required to define these effects and to provide a theoretical model by which to interpret these data. We used a murine model of intraperitoneal cancer to demonstrate the augmentation of tumor growth by surgical trauma. In this intraperitoneal tumor model, a surgical procedure that included entry into the abdominal cavity resulted in augmented tumor growth; a surgical incision on the skin of the animal's back did not promote tumor growth. The immunotherapeutic effects of interleukin-2 and lymphokine-activated killer cells were significantly reduced by the performance of a laparotomy. This abrogation of the effects of the immunotherapeutic regimen was observed for up to 14 days after laparotomy but was lost by days 35 to 42. Healing tissue may promote tumor growth, and these effects are dominant over immunotherapy with interleukin-2 plus lymphokine-activated killer cells.

摘要

宿主对癌症的抵抗力与外科手术创伤之间的相互关系是诸多猜测的主题。需要对动物模型和人类受试者进行广泛研究,以确定这些影响,并提供一个理论模型来解释这些数据。我们使用了一种腹膜内癌症的小鼠模型来证明手术创伤会促进肿瘤生长。在这个腹膜内肿瘤模型中,包括进入腹腔的手术操作导致肿瘤生长加速;在动物背部皮肤做一个手术切口则不会促进肿瘤生长。剖腹手术显著降低了白细胞介素-2和淋巴因子激活的杀伤细胞的免疫治疗效果。剖腹手术后长达14天可观察到免疫治疗方案效果的这种消除,但在第35至42天时消失。愈合组织可能促进肿瘤生长,且这些影响比白细胞介素-2加淋巴因子激活的杀伤细胞的免疫治疗更为显著。

相似文献

1
Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells.剖腹术会促进腹腔内肿瘤生长,并消除白细胞介素-2和淋巴因子激活的杀伤细胞的抗肿瘤作用。
Surgery. 1987 Jul;102(1):71-8.
2
Local regional promotion of tumor growth after abdominal surgery is dominant over immunotherapy with interleukin-2 and lymphokine activated killer cells.
Cancer Detect Prev. 1988;12(1-6):421-9.
3
Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine models.在小鼠模型中,用白细胞介素2和淋巴因子激活的杀伤细胞对腹膜癌进行免疫治疗可降低肿瘤负荷并延长生存期。
Cell Immunol. 1987 Feb;104(2):366-76. doi: 10.1016/0008-8749(87)90038-4.
4
Augmentation of interleukin-2 immunotherapeutic effects by lymphokine-activated killer cells and allogeneic stimulation in murine tumor cells.通过淋巴因子激活的杀伤细胞和异基因刺激增强白细胞介素-2在小鼠肿瘤细胞中的免疫治疗效果。
J Natl Cancer Inst. 1987 Nov;79(5):983-90.
5
The requirements for successful immunotherapy of intraperitoneal cancer using interleukin-2 and lymphokine-activated killer cells.使用白细胞介素-2和淋巴因子激活的杀伤细胞对腹膜癌进行成功免疫治疗的要求。
Cancer. 1987 Oct 1;60(7):1465-73. doi: 10.1002/1097-0142(19871001)60:7<1465::aid-cncr2820600711>3.0.co;2-z.
6
The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.淋巴因子激活的杀伤细胞和重组白细胞介素2在体内的抗肿瘤疗效:已形成转移灶的减少与淋巴因子激活的杀伤细胞的细胞溶解活性之间的直接相关性。
J Immunol. 1986 May 15;136(10):3899-909.
7
Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.用重组白细胞介素2和一种能够诱导抗体依赖性细胞毒性的抗肿瘤单克隆抗体对携带抗淋巴因子激活的杀伤细胞肿瘤的小鼠进行联合治疗。
Cancer Res. 1988 Mar 1;48(5):1173-9.
8
Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.淋巴因子激活的杀伤细胞和重组白细胞介素2在体内的抗肿瘤疗效:对三种不同组织学类型的低免疫原性和无免疫原性小鼠肿瘤所形成的已确立的肺转移灶进行成功的免疫治疗。
Cancer Res. 1986 Oct;46(10):4973-8.
9
Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.用人淋巴细胞激活的杀伤细胞和白细胞介素2对裸鼠人头颈癌异种移植瘤进行局部过继免疫治疗。
Cancer Res. 1990 May 15;50(10):3113-8.
10
Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.牛磺罗定通过消除实体瘤的加速发展和增殖以及手术后释放的循环肿瘤细胞形成器官转移灶,从而提高生存率。
J Surg Res. 2001 Dec;101(2):111-9. doi: 10.1006/jsre.2001.6250.

引用本文的文献

1
Performance of simulated abbreviated liver MRI combined with CT for liver metastasis screening in rectal cancer staging.模拟简化肝脏磁共振成像联合计算机断层扫描在直肠癌分期中用于肝脏转移筛查的性能
Eur Radiol. 2025 Jul 26. doi: 10.1007/s00330-025-11876-8.
2
Risk factors affecting delay of initiating adjuvant chemotherapy for stage III colorectal cancer.影响 III 期结直肠癌辅助化疗起始时间延迟的危险因素。
Int J Clin Oncol. 2024 Sep;29(9):1293-1301. doi: 10.1007/s10147-024-02567-3. Epub 2024 Jun 21.
3
Impact of chemotherapy delay on long-term prognosis of laparoscopic radical surgery for locally advanced gastric cancer: a pooled analysis of four randomized controlled trials.
化疗延迟对腹腔镜局部进展期胃癌根治术长期预后的影响:四项随机对照试验的汇总分析。
Gastric Cancer. 2024 Sep;27(5):1100-1113. doi: 10.1007/s10120-024-01513-6. Epub 2024 May 29.
4
Short-term outcomes of Early versus conventional adjuvant chemotherapy in stage III colon cancer: randomized clinical trial.早期与常规辅助化疗治疗 III 期结肠癌的短期结局:随机临床试验。
BJS Open. 2023 Oct 3;7(4). doi: 10.1093/bjsopen/zrad064.
5
The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer.结直肠癌患者根治术后辅助化疗起始的最佳时间。
BMC Cancer. 2023 May 9;23(1):422. doi: 10.1186/s12885-023-10863-w.
6
Simultaneous versus staged major hepatectomy (≥3 liver segments) for outcomes of synchronous colorectal liver metastases: A systematic review and meta-analysis.同期与分期行 3 段以上肝切除术治疗结直肠肝转移同步性多病灶的效果:系统评价和荟萃分析。
Cancer Rep (Hoboken). 2022 Aug;5(8):e1617. doi: 10.1002/cnr2.1617. Epub 2022 Jun 26.
7
The impact of early adjuvant chemotherapy in rectal cancer.早期辅助化疗对直肠癌的影响。
PLoS One. 2020 Jan 31;15(1):e0228060. doi: 10.1371/journal.pone.0228060. eCollection 2020.
8
Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II/III gastric cancer.辅助化疗中起始时间晚和 S-1 剂量不足可导致 II/III 期胃癌预后不良。
Int J Clin Oncol. 2019 Oct;24(10):1190-1196. doi: 10.1007/s10147-019-01468-0. Epub 2019 May 18.
9
Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis.结直肠癌、胃癌和胰腺癌辅助化疗的时机与生存:一项系统评价和荟萃分析
Cancers (Basel). 2019 Apr 17;11(4):550. doi: 10.3390/cancers11040550.
10
Relationship between initiation time of adjuvant chemotherapy and survival in ovarian cancer patients: a dose-response meta-analysis of cohort studies.辅助化疗起始时间与卵巢癌患者生存的关系:队列研究的剂量反应荟萃分析。
Sci Rep. 2017 Aug 25;7(1):9461. doi: 10.1038/s41598-017-10197-1.